We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Plaintiffs Fear Retaliation In MiraLax Antitrust Suit

Law360 (April 22, 2011, 4:10 PM EDT) -- Plaintiffs in a putative antitrust class action accusing Braintree Laboratories Inc. of initiating baseless patent litigation to block a generic version of the laxative MiraLax asked a Delaware federal court Thursday to bar the company from retaliating against them.

Rochester Drug Cooperative Inc., Louisiana Wholesale Drug Co. and Meijer Inc. — which bought MiraLax directly from Braintree at what they claim was an inflated cost — sought an injunction preventing Braintree from its allegedly retaliatory termination of their supplier relationships, pending a final decision on their...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.